<DOC>
	<DOCNO>NCT00002749</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness carboplatin patient progressive glioma .</brief_summary>
	<brief_title>Carboplatin Patients With Progressive Gliomas</brief_title>
	<detailed_description>OBJECTIVES : I. Assess response carboplatin ( CBDCA ) patient progressive low-grade glioma . II . Assess activity CBDCA stabilize growth tumor . OUTLINE : Single-Agent Chemotherapy . Carboplatin , CBDCA , NSC-241240 . PROJECTED ACCRUAL : A total 25 evaluable patient enter least 1 response first 9 patient .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary intracranial lowgrade glioma ( i.e. , astrocytoma oligodendroglioma ) No 2 year since tissue diagnosis Biopsy require intrinsic chiasmatic mass tumor infiltration along posterior optic tract Evidence progressive disease least one following : Papilledema clinical sign increase intracranial pressure Documented change neuroimaging study , e.g . : Hydrocephalus 25 % increase product maximum perpendicular diameter tumor The following required patient optic pathway glioma : Progressive loss vision document ophthalmologist , i.e . : Doubling octave ( e.g. , 20/20 20/40 20/40 20/80 ) 2 successive visit Loss visual acuity explainable cause , e.g. , medium abnormality amblyopia Greater 3 mm increase proptosis At least 2 mm increase diameter optic nerve neuroimaging Increase distribution tumor involve optic tract optic radiation demonstrate CT MRI use T1 ( without contrast ) T2 image PATIENT CHARACTERISTICS : Age : Any age Performance status : Karnofsky 70 % 100 % Life expectancy : At least 12 week Hematopoietic : ANC least 1,500 Platelets least 100,000 Hemoglobin least 8.0 g/dL Hepatic : Bilirubin le 1.5 time normal ALT le 1.5 time normal Renal : Creatinine le 1.5 mg/dL Other : Negative pregnancy test require fertile woman Effective contraception require fertile patient PRIOR CONCURRENT THERAPY : At least 12 week since radiotherapy ( 4 week since therapy ) recover Prior chemotherapy allow subsequent disease progression</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>childhood low-grade cerebral astrocytoma</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>childhood oligodendroglioma</keyword>
	<keyword>untreated childhood brain stem glioma</keyword>
	<keyword>recurrent childhood brain stem glioma</keyword>
	<keyword>untreated childhood visual pathway glioma</keyword>
	<keyword>recurrent childhood visual pathway glioma</keyword>
	<keyword>untreated childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebral astrocytoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult oligodendroglioma</keyword>
</DOC>